Staphefekt, developed by the Dutch biotechnology company Micreos, is the world's first bacteria-killing enzyme targeting the Staphylococcus aureus-bacteria. It is available in Gladskin creams and gels for people with skin problems.
Scientists create drug to replace antibiotics

Share this article
Bekijk een volgend artikel

Scientists Develop Alternative To Antibiotics

New study suggests S. aureus and skin dysbioses cause eczema